Arecibo 4.5/1.4/0.33-GHz polarimetric single-pulse emission survey von Olszanski, Timothy E E, Mitra, Dipanjan, Rankin, Joanna M

Volltext

Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma von Olszanski, Anthony J.

Volltext

The AO327 Drift Survey Catalog and Data Release of Pulsar Detections von Deneva, J. S., McLaughlin, M., Olszanski, T. E. E., Lewis, E. F., Pang, D., Freire, P. C. C., Bagchi, M., Stovall, K.

Volltext

A mathematical framework for virtual IMRT QA using machine learning von Valdes, G., Scheuermann, R., Hung, C. Y., Olszanski, A., Bellerive, M., Solberg, T. D.

Volltext

Arecibo Investigations of Pulsar B0823+26. I. Plasma Source Changes Configure Its Bright and Quiet Modes von Rankin, Joanna M., Olszanski, Timothy E. E., Wright, Geoffrey A. E.

Volltext

Discovery and Timing of Millisecond Pulsars with the Arecibo 327 MHz Drift-scan Survey von Lewis, Evan F., Olszanski, Timothy E. E., Deneva, Julia S., Freire, Paulo C. C., McLaughlin, Maura A., Stovall, Kevin, Bagchi, Manjari, Martinez, Jose G., Perera, Benetge B. P.

Volltext

Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhi... von Hayat, Umar, Elliott, Gary T., Olszanski, Anthony J., Altieri, Dario C.

Volltext

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) von Mitchell, Tara C, Hamid, Omid, Smith, David C, Bauer, Todd M, Wasser, Jeffrey S, Olszanski, Anthony J, Luke, Jason J, Balmanoukian, Ani S, Schmidt, Emmett V, Zhao, Yufan, Gong, Xiaohua, Maleski, Janet, Leopold, Lance, Gajewski, Thomas F

Volltext

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy von Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John M., Gajewski, Thomas F., Chen, Lisa, Gorski, Kevin S., Anderson, Abraham A., Diede, Scott J., Lassman, Michael E., Gansert, Jennifer, Hodi, F. Stephen, Long, Georgina V.

Volltext

Melanoma in the Bronchus von Manley, Christopher, Olszanski, Anthony

Volltext

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 von Drilon, Alexander, Fu, Siqing, Patel, Manish R, Fakih, Marwan, Wang, Ding, Olszanski, Anthony J, Morgensztern, Daniel, Liu, Stephen V, Cho, Byoung Chul, Bazhenova, Lyudmila, Rodriguez, Cristina P, Doebele, Robert C, Wozniak, Antoinette, Reckamp, Karen L, Seery, Tara, Nikolinakos, Petros, Hu, Zheyi, Oliver, Jennifer W, Trone, Denise, McArthur, Katherine, Patel, Rupal, Multani, Pratik S, Ahn, Myung-Ju

Volltext

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma von Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.

Volltext

Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma von Shoushtari, Alexander N, Olszanski, Anthony J, Nyakas, Marta, Hornyak, Thomas J, Wolchok, Jedd D, Levitsky, Victor, Kuryk, Lukasz, Hansen, Thomas B, Jäderberg, Magnus

Volltext

The effect of 2 different premilking stimulation regimens, with and without a latency period, on teat tissue condition and milking performance in Holstein dairy cows von Singh, A., Geary, C.M., Case, K.L., Juran, I., Olszanski, L., Sytch, N., Womack, S.J., Dahl, M., Spellman, M.E., Wieland, M.

Volltext

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors von Papadopoulos, Kyriakos P, Gluck, Larry, Martin, Lainie P, Olszanski, Anthony J, Tolcher, Anthony W, Ngarmchamnanrith, Gataree, Rasmussen, Erik, Amore, Benny M, Nagorsen, Dirk, Hill, John S, Stephenson, Jr, Joe

Volltext

Viral diversity of Rhipicephalus microplus parasitizing cattle in southern Brazil von Souza, William Marciel de, Fumagalli, Marcílio Jorge, Torres Carrasco, Adriano de Oliveira, Romeiro, Marilia Farignoli, Modha, Sejal, Seki, Meire Christina, Gheller, Janaína Menegazzo, Daffre, Sirlei, Nunes, Márcio Roberto Teixeira, Murcia, Pablo Ramiro, Acrani, Gustavo Olszanski, Figueiredo, Luiz Tadeu Moraes

Volltext

Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors von Infante, Jeffrey R, Dees, E Claire, Olszanski, Anthony J, Dhuria, Shyeilla V, Sen, Suman, Cameron, Scott, Cohen, Roger B

Volltext

Annals of Surgical Oncology Practice Guidelines Series: Adjuvant and Neoadjuvant Therapy for Melanoma von Farma, Jeffrey M., Olszanski, Anthony J., Messina, Jane L., Sondak, Vernon K.

Volltext

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors von Gutierrez, Martin, Moreno, Victor, Heinhuis, Kimberley M, Olszanski, Anthony J, Spreafico, Anna, Ong, Michael, Chu, Quincy, Carvajal, Richard D, Trigo, José, Ochoa de Olza, Maria, Provencio, Mariano, De Vos, Filip Yves, De Braud, Filippo, Leong, Stephen, Lathers, Deanne, Wang, Rui, Ravindran, Palani, Feng, Yan, Aanur, Praveen, Melero, Ignacio

Volltext

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors von RINI, Brian I, SCHILLER, Joan H, KIM, Sinil, RIXE, Olivier, FRUEHAUF, John P, COHEN, Ezra E. W, TARAZI, Jamal C, ROSBROOK, Brad, BAIR, Angel H, RICART, Alejandro D, OLSZANSKI, Anthony J, LETRENT, Kristen J

Volltext